- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01363856
Center for Stroke Research Berlin (CSB) Prospective Stroke Cohort (CSB_PROSCIS)
June 1, 2011 updated by: Charite University, Berlin, Germany
The primary aim of the study is to derive and validate risk scores for vascular endpoints (recurrent stroke, myocardial infarction, and other complications of stroke) and for death following an incident stroke.
For this purpose patients with an incident stroke will be followed for 36 months with additional assessments at 12, 24 and 36 months.
Study Overview
Status
Unknown
Conditions
Detailed Description
Risk of vascular disease including stroke, myocardial infarction, and vascular death is high after stroke but there are only few prognostic models for long term risk up to 3 years.
About 850 patients with an incident stroke will be followed for 3 years with assessments at baseline and at 3, 12, 24, and 36 months.
Factors that have already been reported to be significant predictors of vascular diseases in previous studies as well as new biomarkers (e.g.
neuroimaging, blood based biomarkers) identified in this cohort will be considered.
The improvement of discrimination including these new variables in the models will be investigated.
Several measures of improving predictive properties (e.g.
calibration, discrimination, net reclassification) will be used to compare predictive models with different complexity.
The model will be validated using the bootstrap method (internal validation) and an independent external sample in cooperation with the Institute for Stroke and Dementia Research, Munich.
Study Type
Observational
Enrollment (Anticipated)
750
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 10117
- Recruiting
- Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin
-
Contact:
- Peter U Heuschmann, MD, MPH
- Phone Number: +49 (0)30 450560611
- Email: peter.heuschmann@charite.de
-
Contact:
- Thomas G Liman, MD
- Phone Number: +49 (0)30 450560643
- Email: thomas.liman@charite.de
-
Principal Investigator:
- Peter U Heuschmann, MD, MPH
-
Munich, Germany
- Recruiting
- Interdisciplinary Stroke Center Munich, Klinikum der Universität München, Campus Großhadern
-
Contact:
- Martin Dichgans, MD
- Phone Number: +49 (0)89 7095 Ext. 8310
- Email: martin.dichgans@med.uni-muenchen.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients admitted to a specialized stroke service because of an acute stroke
Description
Inclusion Criteria:
- Age ≥18 years
- Language: German
- First ever stroke including ischemic stroke, primary intracranial hemorrhage and cerebral venous sinus thrombosis that occurred with stroke onset in the last 7 days
- Written informed consent by patient prior to study participation
- Willingness to participate in follow-up
Exclusion Criteria:
- Prior stroke (definition according to WHO definition)
- Patients presenting brain tumour or brain metastasis
- Participation in an intervention- / AMG-study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
First ever acute stroke
Patients over 18 years and without prior stroke according to WHO criteria, displaying an ischemic stroke, onset within the last 7 days, language German
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Combined vascular endpoint composed of stroke, myocardial infarction, and vascular death
Time Frame: 36 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by hospital or physician.
|
36 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Combined vascular endpoint composed of stroke, myocardial infarction, and vascular death
Time Frame: 24 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by hospital or physician.
In case of death of the patient, evaluation will be based on data from the registry office
|
24 months
|
|
Combined vascular endpoint composed of stroke, myocardial infarction, and vascular death
Time Frame: 12 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by hospital or physician.
In case of death of the patient, evaluation will be based on data from the registry office
|
12 months
|
|
Course of cognitive function
Time Frame: 36 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by the physician
|
36 months
|
|
Course of depression
Time Frame: 36 months
|
This evaluation will be based on a structured interview with the patient.
In case of positive screening more information will be obtained by the physician
|
36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Peter U Heuschmann, MD MPH, Center for Stroke Research Berlin, Charité Campus Mitte
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Stillfried MRV, Sperber PS, Broersen LHA, Huo S, Piper SK, Heuschmann PU, Endres M, Siegerink B, Liman TG. Low ankle-brachial index and cognitive function after stroke-the PROSpective with Incident Stroke Berlin (PROSCIS-B). Front Neurol. 2022 Sep 28;13:963262. doi: 10.3389/fneur.2022.963262. eCollection 2022.
- Scheitz JF, Lim J, Broersen LHA, Ganeshan R, Huo S, Sperber PS, Piper SK, Heuschmann PU, Audebert HJ, Nolte CH, Siegerink B, Endres M, Liman TG. High-Sensitivity Cardiac Troponin T and Recurrent Vascular Events After First Ischemic Stroke. J Am Heart Assoc. 2021 May 18;10(10):e018326. doi: 10.1161/JAHA.120.018326. Epub 2021 May 13.
- Huo S, Krankel N, Nave AH, Sperber PS, Rohmann JL, Piper SK, Heuschmann PU, Landmesser U, Endres M, Siegerink B, Liman TG. Endothelial and Leukocyte-Derived Microvesicles and Cardiovascular Risk After Stroke: PROSCIS-B. Neurology. 2021 Feb 9;96(6):e937-e946. doi: 10.1212/WNL.0000000000011223. Epub 2020 Nov 12.
- Broersen LHA, Siegerink B, Sperber PS, von Rennenberg R, Piper SK, Nolte CH, Heuschmann PU, Endres M, Scheitz JF, Liman TG. High-Sensitivity Cardiac Troponin T and Cognitive Function in Patients With Ischemic Stroke. Stroke. 2020 May;51(5):1604-1607. doi: 10.1161/STROKEAHA.119.028410. Epub 2020 Apr 13.
- Sperber PS, Siegerink B, Huo S, Rohmann JL, Piper SK, Pruss H, Heuschmann PU, Endres M, Liman TG. Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B). Stroke. 2019 Nov;50(11):3213-3219. doi: 10.1161/STROKEAHA.119.026100. Epub 2019 Sep 17. Erratum In: Stroke. 2019 Nov;50(11):e343.
- Liman TG, Zietemann V, Wiedmann S, Jungehuelsing GJ, Endres M, Wollenweber FA, Wellwood I, Dichgans M, Heuschmann PU. Prediction of vascular risk after stroke - protocol and pilot data of the Prospective Cohort with Incident Stroke (PROSCIS). Int J Stroke. 2013 Aug;8(6):484-90. doi: 10.1111/j.1747-4949.2012.00871.x. Epub 2012 Aug 29.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Anticipated)
June 1, 2013
Study Completion (Anticipated)
June 1, 2015
Study Registration Dates
First Submitted
May 31, 2011
First Submitted That Met QC Criteria
June 1, 2011
First Posted (Estimate)
June 2, 2011
Study Record Updates
Last Update Posted (Estimate)
June 2, 2011
Last Update Submitted That Met QC Criteria
June 1, 2011
Last Verified
May 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSB_PROSCIS_01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.